All myalgic encephalomyelitis/chronic fatigue syndrome articles
-
NewsStart-up EBViously announces its launch
EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV).
-
NewsME linked to changes in the gut microbiome and metabolites
Two studies have found that myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is associated with reduced levels in the gastrointestinal microbiome of microbes known to produce the fatty acid butyrate, disruptions that could explain in part how the immune system becomes disrupted in people with ME/CFS.